[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
[ Tue, May 07th 2024 ]: WOPRAI
Andrew Fein Reiterated (STOK) at Strong Buy and Held Target at $35 on, May 7th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Andrew Fein of HC Wainwright & Co., Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $35 on, May 7th, 2024.
Andrew has made no other calls on STOK in the last 4 months.
There are 5 other peers that have a rating on STOK. Out of the 5 peers that are also analyzing STOK, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $13 on, Tuesday, March 26th, 2024
These are the ratings of the 4 analyists that currently disagree with Andrew
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $22 on, Monday, May 6th, 2024
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, April 4th, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $17 on, Tuesday, March 26th, 2024
- Yaron Werber of "TD Cowen" Upgraded from Hold to Strong Buy on, Tuesday, March 26th, 2024